Current version | Deadline for comments: 30/09/2016 |
Reference number | EMA/CVMP/ADVENT/207268/2016 |
Published | 25/07/2016 |
Keywords | mesenchymal stem cells (MSCs), veterinary, tumorigenicity, homogeneity, biodistribution, amplification |
Description | This problem statement provides the basis for development of a guidance on tumorigenicity in relation to stem cell products intended for veterinary use. If you have any comments on the content of the document, use this. The completed comments form should be sent to vet-guidelines@ema.europa.eu. |